Privia Health Group Inc header image

Privia Health Group Inc

PRVA

Equity

ISIN null / Valor 111013233

NASDAQ (2025-11-21)
USD 23.74+5.28%

Privia Health Group Inc
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Privia Health Group Inc is a national physician organization that focuses on transforming the healthcare delivery experience for both providers and consumers. Through the use of talent, tools, and technology, the company has successfully developed and scaled physician groups to top-tier performance levels. Privia Health aims to enhance the patient-provider relationship by providing tools and technology designed to improve healthcare outcomes, reduce costs, and enhance the well-being of both patients and providers.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (09.10.2025):

Privia Health Group Inc reported strong financial results for the second quarter of 2025, demonstrating significant growth in key operating and financial metrics. The company saw a 23.4% increase in total revenue compared to the same quarter last year, alongside substantial gains in practice collections and non-GAAP adjusted net income. Additionally, Privia raised its full-year guidance, reflecting confidence in continued performance and strategic investments.

Revenue Growth

Total revenue for Q2 2025 reached $521.2 million, marking a 23.4% increase from $422.3 million in Q2 2024. This growth underscores Privia's expanding market presence and effective revenue-generating strategies.

Practice Collections Increase

Practice collections rose by 18.5% year-over-year, totaling $862.9 million in Q2 2025 compared to $728.0 million in the previous year. This increase highlights the company's successful efforts in enhancing its service offerings and provider network.

Non-GAAP Adjusted Net Income

Non-GAAP adjusted net income surged by 30.1%, reaching $30.6 million in Q2 2025 compared to $23.5 million in Q2 2024. This significant growth reflects improved operational efficiency and effective cost management.

Guidance Raised

Privia Health has raised its full-year 2025 guidance to the high end of its projected range for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA. This adjustment demonstrates the company's positive outlook and confidence in sustaining its growth trajectory.

Financial Stability

The company maintains a strong liquidity position with $390.1 million in cash and no debt, following the deployment of $95 million for the IMS transaction in Arizona. This financial stability provides a solid foundation for future investments and strategic initiatives.

Summarized from source with an LLMView Source

Key figures

12.6%1Y
4.03%3Y
%5Y

Performance

33.1%1Y
40.8%3Y
51.1%5Y

Volatility

Market cap

2914 M

Market cap (USD)

Daily traded volume (Shares)

761,647

Daily traded volume (Shares)

1 day high/low

19.78 / 19.18

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
5.00
Fabian Stalder
Switzerland, 27 Mar 2025
star star star star star
Hohes Potenzial

EQUITIES OF THE SAME SECTOR

Vertex Inc
Vertex Inc Vertex Inc Valor: 55908112
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%USD 19.79
All for One Group SE
All for One Group SE All for One Group SE Valor: 192106
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.46%EUR 39.80
AIXTRON SE
AIXTRON SE AIXTRON SE Valor: 4566068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.21%EUR 16.32
Procore Technologies Inc
Procore Technologies Inc Procore Technologies Inc Valor: 53026320
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.30%USD 71.09
Entegris Inc
Entegris Inc Entegris Inc Valor: 1102899
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.06%USD 73.66
Exact Sciences Corp
Exact Sciences Corp Exact Sciences Corp Valor: 1183218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 100.90
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%CHF 303.00
RxSight Inc
RxSight Inc RxSight Inc Valor: 112649019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.41%USD 10.15
stock3 AG
stock3 AG stock3 AG Valor: 117302445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%EUR 29.80
paragon GmbH & Co. KGaA
paragon GmbH & Co. KGaA paragon GmbH & Co. KGaA Valor: 1150842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.33%EUR 2.17